Abdominal wall haematoma and drugs of ingredients of insulin aspart recombinant - a phase IV clinical study of FDA data


Summary:

Abdominal wall haematoma is found among people who take drugs with ingredients of insulin aspart recombinant, especially for people who are female, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 73,166 people who have side effects when taking drugs with ingredients of insulin aspart recombinant from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Novolog, Novolog flexpen, Novolog flextouch, Novolog innolet, Novolog penfill, Novorapid.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Nov, 27, 2022

73,166 people reported to have side effects when taking drugs with ingredients of insulin aspart recombinant.
Among them, 14 people (0.02%) have Abdominal wall haematoma


What is Abdominal wall haematoma?

Abdominal wall haematoma (abdominal wall blood clotting) is found to be associated with 825 drugs and 489 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of insulin aspart recombinant cause Abdominal wall haematoma?

Gender of people who have Abdominal wall haematoma when taking drugs with ingredients of insulin aspart recombinant *:

  • female: 90 %
  • male: 10 %

Age of people who have Abdominal wall haematoma when taking drugs with ingredients of insulin aspart recombinant *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Conditions people have *:

  1. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 28.57%
  2. Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 14.29%
  3. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 14.29%
  4. Pain: 2 people, 14.29%
  5. Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 2 people, 14.29%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
  7. Thrombophlebitis Superficial (swelling (inflammation) of a superficial vein caused by a blood clot): 1 person, 7.14%
  8. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 7.14%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.14%
  10. Breathing Difficulty: 1 person, 7.14%

Other drugs people take *:

  1. Lasix: 5 people, 35.71%
  2. Lantus: 4 people, 28.57%
  3. Crestor: 4 people, 28.57%
  4. Synthroid: 3 people, 21.43%
  5. Neurontin: 3 people, 21.43%
  6. Xarelto: 3 people, 21.43%
  7. Neupogen: 2 people, 14.29%
  8. Heparin: 2 people, 14.29%
  9. Hydrocortisone: 2 people, 14.29%
  10. Pradaxa: 2 people, 14.29%

Other side effects people have besides Abdominal wall haematoma *:

  1. Abdominal Pain: 3 people, 21.43%
  2. Anaemia (lack of blood): 3 people, 21.43%
  3. Haemorrhagic Anaemia (anaemia due to excessive bleeding): 2 people, 14.29%
  4. Hepatic Vein Thrombosis (obstruction in the veins of the liver caused by a blood clot): 2 people, 14.29%
  5. Vaginal Bleeding: 2 people, 14.29%
  6. Inflammation: 2 people, 14.29%
  7. Kidney Infection (Pyelonephritis): 2 people, 14.29%
  8. Muscle Haemorrhage (bleeding in muscle): 2 people, 14.29%
  9. Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 2 people, 14.29%
  10. Overdose: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.


How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of insulin aspart recombinant, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: